Article

Novel risk factors for venous thromboembolism.

Department of Clinical Medicine, University of Insubria, UO Medicina I, Ospedale di Circolo, Varese, Italy.
Hematology/oncology clinics of North America (impact factor: 2.05). 08/2010; 24(4):709-16, viii. DOI:10.1016/j.hoc.2010.05.007 pp.709-16, viii
Source: PubMed

ABSTRACT VTE can be considered as a multicausal disease involving various inherited and acquired prothrombotic conditions. Although greater emphasis has classically been given to traditional thrombophilic risk factors, there is increasing recognition of less typical precipitating conditions and events. In this article, the authors focus on the most promising, persistent, and potentially treatable novel risk factors.

0 0
 · 
0 Bookmarks
 · 
28 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

promising
 
traditional thrombophilic risk factors
 
treatable novel risk factors
 
typical precipitating conditions
 
various